Navigation Links
Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer
Date:5/13/2008

PHILADELPHIA, May 13 /PRNewswire-USNewswire/ -- In women at increased risk for breast cancer, adding a screening ultrasound examination to routine mammography revealed 28 percent more cancers than mammography alone. However, the additional ultrasound exam substantially increased the rates of false positive findings and unnecessary biopsies, according to an American College of Radiology Imaging Network (ACRIN) study published in the May 14, 2008 issue of the Journal of American Medical Association.

This ACRIN study enrolled 2,809 women at increased risk for breast cancer at 21 sites and 2,637 of these women were eligible for analysis. The criteria used to determine an increased breast cancer risk included: participant age of 25 years or older, dense breasts, prior atypical breast biopsy, personal and/or or moderate family history of breast cancer. The study was made possible through funding from a novel private-public partnership between the Avon Foundation and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

Forty women were diagnosed with breast cancer within 12 months of the initial screening. Mammography alone revealed 20 cancers (50 percent of all cancers detected) for a cancer detection rate of 7.6 women per 1,000 women screened, though one cancer was dismissed. The combination of mammography plus screening ultrasound revealed 31 cancers (78 percent of all cancers detected) for a cancer detection rate of 11.8 women per 1,000 women screened. Eight of the 40 cancers were not seen with either mammography or ultrasound at the time of the initial screen, but were discovered later during the twelve month period for a rate of three cancers missed per 1,000 women screened.

The risk of incurring an unnecessary biopsy due to a false positive exam result from the supplemental screening ultrasound was also substantially increased in this study. Mammography alone prompted an unnecessary biopsy for one in
'/>"/>

SOURCE American College of Radiology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
5. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
6. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
7. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
8. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
9. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
10. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
11. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ARK,Calif.,Nov.25/PRNewswire/--PraxisElectronicMed...AcademyofFamilyPhysicians,(AAFP)FamilyPracticeMana...ngmedicalquality,healthmaintenance,anddiseasemanag...xisalsoranked#1amongdoctorsindicatingtheirEMRhadap...isalsorankednumberoneinthecountryinprovidingexcell...
(Date:11/25/2009)...ON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharmasset,I...panycommittedtodiscovering,developingandcommercial...ncialresultsforthefiscalyearendedSeptember30,2009....,cashequivalentsandshortterminvestments. ,, Pi..., Phase2bTrial ,, InlateNovember2009,aninde...
(Date:11/25/2009)...ATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedtraditi...anon-nucleosidereversetranscriptaseinhibitor(NNRTI...seintreatment-experiencedadultswhoareexperiencingv...ndotherantiretroviral(ARV)agents.Thetraditionalapp...asDUET-1andDUET-2.INTELENCEiscurrentlymarketedinth...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Surgery Sham Equal in Treating Compression Fracture Pain 53774 1Surgery Sham Equal in Treating Compression Fracture Pain 53774 2Surgery Sham Equal in Treating Compression Fracture Pain 53774 3PDI Reports 2009 Second Quarter Financial Results 13399 1PDI Reports 2009 Second Quarter Financial Results 13399 2PDI Reports 2009 Second Quarter Financial Results 13399 3PDI Reports 2009 Second Quarter Financial Results 13399 4PDI Reports 2009 Second Quarter Financial Results 13399 5PDI Reports 2009 Second Quarter Financial Results 13399 6PDI Reports 2009 Second Quarter Financial Results 13399 7PDI Reports 2009 Second Quarter Financial Results 13399 8PDI Reports 2009 Second Quarter Financial Results 13399 9Orexigen 28R 29 Therapeutics to Speak at Canaccord Adams Global Growth Conference 13397 1
...ca show vital need for new products that can be ...R and NEW ORLEANS, May 7 Corgenix Medical Corpora...oper and marketer of diagnostic test kits, has ann...r developing test kits for the detection of viral ...utes of Health (NIH) has awarded a five-year grant...
...euticals Inc. (Nasdaq: VNDA ) announced today th...ranted marketing approval of Fanapt(TM) (iloperido... schizophrenia. The approval was supported by two ...aring Fanapt(TM) to placebo and active control in ...a from more than 3,000 patients. , , Fanapt(TM) i...
Other Medicine Technology:Corgenix, Tulane Announce Award of NIH Grant Extending Hemorrhagic Fever Virus Product Development Program 2Corgenix, Tulane Announce Award of NIH Grant Extending Hemorrhagic Fever Virus Product Development Program 3Corgenix, Tulane Announce Award of NIH Grant Extending Hemorrhagic Fever Virus Product Development Program 4FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 2FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 3FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 4FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 5FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 6FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 7
(Date:11/25/2009)... Evaluation and treatment clinics to resu...stock (Vocus) November 25, 2009 -- Centegra Health... and H1N1 vaccine shots at four Centegra Primary C...nt of vaccine has arrived. The clinics are at CPC ...nry and will be open as follows: ,   F...
(Date:11/25/2009)...plagued by neurological symptoms, study finds , ...Neurological side effects are among the potential ...r cancer who were treated with cisplatin-based che...ncluded 1,409 Norwegian men treated for unilateral...part in a follow-up survey conducted from 1998 to ...
(Date:11/25/2009)...Nov.25/PRNewswire/-- MISSIONSkincare ®isproud....Jude.AspartofGNC,sannualSt.Jude ThanksandGiving c...are,s new SUPER-C(TM)LipBalm willbedonatedtoSt.J...akea$1,$5or$10donationatcheckoutatoneoftheir5,000+...$1millionforSt.Judeduringtheir2009 ThanksandGiving...
(Date:11/25/2009)...ImprovementShownforthe4thStraightYear ,, WASH...CancerAlliance-Georgia(LCA-GA)issuedthe 4thAnnualR...rogressbeingmadeagainstthislethaldiseaseinthestate...),theonlynationalorganizationdedicatedexclusivelyt...iskforlungcancer. ,, (Logo: http://www.newscom....
(Date:11/25/2009)... treat colorectal cancer also can reverse a rare s...e therapy for the disease, researchers at Vanderbi...Mntrier,s disease causes thickening of the stomach...g, as well as anemia and swelling in the feet and ...sed risk for gastric cancer. Previously, the only ...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2
... music has gone from an art form that largely warn...hat often glorifies illegal drug use, according to...genre covering nearly two decades. The study is p...over time, and drug references increased overall, ...
...stem is obstructing good patient care , , ... American doctors now support the concept of natio...thinking over the past five years, a new survey fi...everyone. In most cases, these plans eliminate or ...
...fat, leaving them prone to heart disease, diabetes...Despite appearances to the contrary, more than hal...e of body fat. And, like their overweight contempo...0 percent and women whose body fat is greater than...
...th Melanin-Rich Skin Tones, SKILLMAN, N.J., April...women with melanin-rich skin tones between,the age...sis,[1] however,the condition is not the only skin...n in their skin that often leaves,behind darks mar...
...s Participating in National Casting Call ...exas, April 1 In celebration of Earth Month,Whole...anic foods,supermarket, today announced that six f...edicated to raising,environmental awareness among ...
...ng Old Fashioned Medicine with a High ... April 1, 2008 MedeFile,International, Inc. (OTC ...ortable electronic medical records management solu...mpower their,patients with personal convenience an...
Other Medicine News:Health News:Drug use increasingly glamorized in rap music, according to new study of 2-decade trends 2Health News:Drug use increasingly glamorized in rap music, according to new study of 2-decade trends 3Health News:Majority of U.S. Doctors Back National Insurance Plan 2Health News:Normal Weight Doesn't Always Equal Healthy Weight 2Health News:Normal Weight Doesn't Always Equal Healthy Weight 3Health News:AMBI(R) Introduces SOFT & EVEN(TM) 2Health News:AMBI(R) Introduces SOFT & EVEN(TM) 3Health News:Whole Foods Market(R) Announces Eco-Conscious Youth Hosts for 'Whole Earth Generation(TM)' Show 2Health News:Whole Foods Market(R) Announces Eco-Conscious Youth Hosts for 'Whole Earth Generation(TM)' Show 3Health News:Whole Foods Market(R) Announces Eco-Conscious Youth Hosts for 'Whole Earth Generation(TM)' Show 4Health News:Personal Choice Family Practice Empowers Patients With MedeFile Electronic Medical Records Management Solution 2Health News:Personal Choice Family Practice Empowers Patients With MedeFile Electronic Medical Records Management Solution 3Health News:Personal Choice Family Practice Empowers Patients With MedeFile Electronic Medical Records Management Solution 4Health News:Personal Choice Family Practice Empowers Patients With MedeFile Electronic Medical Records Management Solution 5Health News:Personal Choice Family Practice Empowers Patients With MedeFile Electronic Medical Records Management Solution 6
VICTOR2 with fluorescence, fluorescence polarization and luminescence technologes
VICTOR2 with fluorescence and luminescence technologies, stackers and robotic loading system
Modular VICTOR2 multilabel counter with TR-fluorometry
...-channel parallel detection of fluorescence, absor...icrotiter plates. Compact workstations and system...port of microtiter plates with a throughput of > 1...itching required by numerous other systems to star...
Medicine Products: